RX658 RX658 RX658 RX658 (Cefaclor 250 mg)
Pill imprint RX658 RX658 RX658 RX658 has been identified as Cefaclor 250 mg.
Cefaclor is used in the treatment of tonsillitis/pharyngitis; skin and structure infection; bronchitis; skin infection; urinary tract infection (and more), and belongs to the drug class second generation cephalosporins. There is no proven risk in humans during pregnancy. Cefaclor 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for RX658 RX658 RX658 RX658 (Cefaclor 250 mg)
- Imprint:
-
RX658 RX658
RX658 RX658 - Strength:
- 250 mg
- Color:
- Blue / White
- Size:
- 18.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Second generation cephalosporins
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Ranbaxy Pharmaceuticals Inc.
- National Drug Code (NDC):
- 63304-0658
- Inactive Ingredients:
- silicon dioxide colloidal
croscarmellose sodium
D&C Yellow No. 10
D&C Red No. 28
FD&C Blue No. 1
FD&C Red No. 40
gelatin
magnesium stearate
pregelatinized starch
titanium dioxide
| NDC Code | Manufacturer / Repackager |
|---|---|
| 66267-0262 | Nucare Pharmaceuticals Inc (repackager) |
| 68115-0065 | Dispensexpress Inc (repackager) |
| 63874-0119 | Altura Pharmaceuticals Inc (repackager) |
| 66336-0202 | Dispensing Solutions Inc. (repackager) |
| 16590-0041 | Stat RX USA LLC (repackager) |
| 23490-5218 | Palmetto State Pharmaceuticals Inc (repackager) |
| 33358-0065 | Core Pharmaceuticals Inc (repackager) |
| 53002-0211 | Pharmedix (repackager) |
Note: Inactive ingredients may vary.
More resources
Cefaclor is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
